Financhill
Buy
56

BAYRY Quote, Financials, Valuation and Earnings

Last price:
$10.54
Seasonality move :
-1.39%
Day range:
$10.49 - $10.55
52-week range:
$4.79 - $10.71
Dividend yield:
0.29%
P/E ratio:
--
P/S ratio:
0.82x
P/B ratio:
1.19x
Volume:
291.5K
Avg. volume:
506.2K
1-year change:
116.22%
Market cap:
$41.4B
Revenue:
$50.4B
EPS (TTM):
-$0.09

Earnings Data

Next earnings date for BAYRY
Feb 25
2026
Most recent earnings per share
-$0.29
Missed by $0.41
(Nov 12/2025)
Consensus Estimate
$0.13
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BAYRY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $13B -- -- $0.15 --
11/12/2025 Q3 $11.2B $11.3B -$0.29 $0.13 -$0.41
08/06/2025 Q2 $12.5B $12.2B -$0.06 $0.25 -$0.31
05/13/2025 Q1 $15.2B $14.5B $0.35 $0.69 -$0.34
03/05/2025 Q4 $11.9B $12.5B -$0.09 $0.26 -$0.35
11/12/2024 Q3 $11.1B $11B -$1.17 $0.17 -$1.34
08/06/2024 Q2 $11.9B $12B -$0.01 $0.25 -$0.26
05/10/2024 Q1 $15.2B $14.9B $0.55 $0.42 $0.13
03/05/2024 Q4 $12.6B $12.8B $0.37 $0.45 -$0.09
11/08/2023 Q3 $11.2B $11.3B -$1.26 $0.27 -$1.54
08/08/2023 Q2 -- $12B -$0.52 -- --
05/11/2023 Q1 -- $15.4B $0.59 -- --
02/28/2023 Q4 -- $12.2B $0.16 -- --
11/08/2022 Q3 -- $11.4B $0.14 -- --
08/04/2022 Q2 -- $13.6B -$0.08 -- --
05/10/2022 Q1 -- $16.4B $0.94 -- --
03/01/2022 Q4 -- $12.7B $0.34 -- --
11/09/2021 Q3 -- $11.5B $0.03 -- --
08/05/2021 Q2 -- $13.1B -$0.72 -- --
05/12/2021 Q1 -- $14.8B $0.64 -- --
02/25/2021 Q4 -- $11.9B $0.09 -- --
11/03/2020 Q3 -- $9.9B -$0.82 -- --
08/04/2020 Q2 -- $11.1B -$2.68 -- --
04/27/2020 Q1 -- $14.2B $0.42 -- --
02/27/2020 Q4 -- $11.9B $0.40 -- --
10/30/2019 Q3 -- $10.9B $0.29 -- --
07/30/2019 Q2 -- $12B $0.12 -- --
04/26/2019 Q1 -- $13.9B $0.36 -- --
02/27/2019 Q4 -- $11.8B -$1.20 -- --
11/13/2018 Q3 -- $10.8B $0.85 -- --
09/05/2018 Q2 -- $11.3B $0.26 -- --
05/03/2018 Q1 -- $11.2B $0.68 -- --
02/28/2018 Q4 -- $10.1B $0.05 -- --
10/26/2017 Q3 -- $9.4B $1.29 -- --
07/27/2017 Q2 -- $9.6B $0.37 -- --
04/27/2017 Q1 -- $10.3B $0.63 -- --
02/22/2017 Q4 -- $9.5B $0.14 -- --
10/26/2016 Q3 -- $9.2B $0.39 -- --
07/27/2016 Q2 -- $13.4B $0.46 -- --
04/26/2016 Q1 -- $13.1B $0.50 -- --
02/25/2016 Q4 -- $12.4B $0.20 -- --

Bayer AG Earnings Questions

  • How Much did Bayer AG Generate in Revenue Last Quarter?

    Bayer AG reported $11.3B worth of top line sales in its most recent quarter.

  • Did Bayer AG Beat Earnings Last Quarter?

    Bayer AG announced earnings per share of -$0.29 which represents a miss of analyst forecast a $0.13 per share.

  • Is Bayer AG Profitable?

    Bayer AG reported $6.3B that represents $1.59 per share over the last quarter.

  • What is the Analyst Consensus for Bayer AG EPS Next Year?

    Bayer AG's earnings are forecast to grow from -$0.70 per share to $3.19 per share next year representing an increase of 52.19%.

  • When is Bayer AG's Earnings Date?

    Bayer AG's next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock